Total Payments
$10,048
2024 Payments
$2,922
Companies
65
Transactions
569
Medicare Patients
19,809
Medicare Billing
$7.7M
Payment Breakdown by Category
Food & Beverage$9,598 (95.5%)
Education$330.21 (3.3%)
Other$120.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,598 | 558 | 95.5% |
| Education | $330.21 | 9 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $120.00 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $980.52 | 63 | $0 (2024) |
| PFIZER INC. | $906.83 | 52 | $0 (2024) |
| Merck Sharp & Dohme LLC | $760.38 | 43 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $541.18 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $498.72 | 26 | $0 (2024) |
| Seagen Inc. | $434.36 | 30 | $0 (2023) |
| Incyte Corporation | $403.15 | 19 | $0 (2024) |
| Genentech USA, Inc. | $353.98 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $330.46 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $262.01 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,922 | 149 | PFIZER INC. ($508.68) |
| 2023 | $2,445 | 141 | Novartis Pharmaceuticals Corporation ($331.49) |
| 2022 | $2,106 | 120 | Seagen Inc. ($221.23) |
| 2021 | $107.15 | 3 | Coherus Biosciences Inc. ($75.00) |
| 2020 | $480.24 | 30 | Merck Sharp & Dohme Corporation ($70.64) |
| 2019 | $1,859 | 117 | PFIZER INC. ($200.48) |
| 2018 | $129.85 | 9 | PFIZER INC. ($50.21) |
All Payment Transactions
569 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Hematology | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Oncology | ||||||
| 12/06/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/25/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Hematology/Oncology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.77 | General |
| 11/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Iovance Biotherapeutics, Inc. | Amtagvi (Drug) | Food and Beverage | Cash or cash equivalent | $12.13 | General |
| Category: Oncology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $22.62 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: HORMONE THERAPY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Oncology | ||||||
| 11/06/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.84 | General |
| 10/31/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Hematology | ||||||
| 10/30/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Oncology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 80 | 7,733 | 105,009 | $10.9M | $3.1M |
| 2022 | 89 | 7,371 | 149,127 | $12.9M | $3.3M |
| 2021 | 68 | 4,705 | 48,435 | $4.5M | $1.3M |
Total Patients
19,809
Total Services
302,571
Medicare Billing
$7.7M
Procedure Codes
237
All Medicare Procedures & Services
237 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 44 | 49,000 | $6.9M | $2.1M | 30.9% |
| Q5127 | Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg | Office | 2023 | 25 | 864 | $1.1M | $233,058 | 22.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 36 | 7,680 | $499,200 | $141,921 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 485 | 1,473 | $294,600 | $134,168 | 45.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 148 | 686 | $274,400 | $61,544 | 22.4% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 22 | 2,300 | $172,500 | $38,824 | 22.5% |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | Office | 2023 | 15 | 360 | $333,000 | $35,964 | 10.8% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 39 | 90 | $135,000 | $28,553 | 21.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 728 | 2,283 | $98,169 | $23,413 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 730 | 2,312 | $23,120 | $19,406 | 83.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 750 | 2,378 | $83,230 | $17,962 | 21.6% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 11 | 5,805 | $58,050 | $13,584 | 23.4% |
| J1750 | Injection, iron dextran, 50 mg | Office | 2023 | 32 | 932 | $41,940 | $12,476 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $30,000 | $11,325 | 37.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 150 | 962 | $96,200 | $10,395 | 10.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 121 | 231 | $46,200 | $10,109 | 21.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 381 | 622 | $21,770 | $8,234 | 37.8% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 12 | 52 | $137,800 | $8,170 | 5.9% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 11 | 5,980 | $29,900 | $8,055 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 62 | $18,600 | $8,024 | 43.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 40 | 165 | $33,000 | $7,479 | 22.7% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 26 | 435 | $71,775 | $6,952 | 9.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 140 | 411 | $18,495 | $6,765 | 36.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 308 | 441 | $15,435 | $6,488 | 42.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 64 | 278 | $27,800 | $5,532 | 19.9% |
About Heather Brody
Heather Brody is a Hematology & Oncology healthcare provider based in Florence, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1013301563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Brody has received a total of $10,048 in payments from pharmaceutical and medical device companies, with $2,922 received in 2024. These payments were reported across 569 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($9,598).
As a Medicare-enrolled provider, Brody has provided services to 19,809 Medicare beneficiaries, totaling 302,571 services with total Medicare billing of $7.7M. Data is available for 3 years (2021–2023), covering 237 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Florence, AL
- Active Since 03/23/2015
- Last Updated 04/22/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013301563
Products in Payments
- KEYTRUDA (Biological) $702.42
- OPDIVO (Biological) $367.80
- KISQALI (Drug) $296.30
- XTANDI (Drug) $291.18
- IMFINZI (Biological) $253.83
- JAKAFI (Drug) $232.43
- IBRANCE (Drug) $221.67
- ADCETRIS (Biological) $183.54
- PADCEV (Biological) $181.23
- Lenvima (Drug) $174.82
- TUKYSA (Drug) $164.99
- ZEJULA (Drug) $161.48
- GILOTRIF (Drug) $158.10
- IMBRUVICA (Drug) $145.48
- Udenyca (Biological) $141.17
- PROMACTA (Drug) $139.78
- PLUVICTO (Drug) $131.74
- VERZENIO (Drug) $127.93
- XALKORI (Drug) $124.18
- REBLOZYL (Biological) $123.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Florence
Dr. Mark Keaton, M.d, M.D
Hematology & Oncology — Payments: $30,744
Hematology & Oncology $30,744
Dr. Clint Kingsley, Md, MD
Hematology & Oncology — Payments: $21,594
Hematology & Oncology $21,594
Rajesh Bajaj, M.d, M.D
Hematology & Oncology — Payments: $18,826
Hematology & Oncology $18,826
Ravneet Bajwa, M.d, M.D
Hematology & Oncology — Payments: $4,477
Hematology & Oncology $4,477
Dr. Anthony Kalliath, Md, MD
Hematology & Oncology — Payments: $2,727
Hematology & Oncology $2,727
James Smith, Md, MD
Hematology & Oncology — Payments: $2,684
Hematology & Oncology $2,684